Can Abbott’s connected neuromodulation platforms improve life for chronic pain and movement disorder patients?

About this episode

The episode discusses Abbott's advancements in neuromodulation technologies for chronic pain and movement disorders.

In the final episode of AbbottTalks season 3, hosts Tom Salemi and Kayleen Brown sit down with Rebecca Wilkins, divisional vice president of R&D for Abbott’s Neuromodulation business, to discuss the technologies Abbott is advancing for chronic pain and movement disorders.Wilkins explains how Abbott’s spinal cord stimulation platforms, Proclaim™ DRG Neurostimulation System, and Infinity™ deep brain stimulation system are designed to interrupt errant nervous system signals, helping patients manage conditions ranging from chronic pain and Parkinson’s disease to, potentially, treatment-resistant depression.The conversation also highlights the features shaping Abbott’s neuromodulation portfolio, including Bluetooth-enabled connectivity, the NeuroSphere™ Virtual Clinic for remote programming, improved MRI compatibility including prone MRI access, and device options that balance small size with low recharge demands.Wilkins also shares new data presented at NANS showing significant reductions in pain-related healthcare encounters for patients using Abbott’s spinal cord stimulation and DRG therapies. This episode is brought to you by Confluent Medical Technologies. To learn more about…

People in this episode

Hosts: Tom Salemi, Kayleen Brown

Guest: Rebecca Wilkins

Topics covered

• neuromodulation
• chronic pain
• movement disorders
• health technology
• patient care

Keywords

• neuromodulation
• chronic pain
• deep brain stimulation
• spinal cord stimulation
• healthcare technology

Sponsors

Confluent Medical Technologies

Mentioned in this episode

Organizations: Abbott

Products: Proclaim™ DRG Neurostimulation System, Infinity™ deep brain stimulation system

More episodes of DeviceTalks Podcast Network

• Intuitive's Hutton on Why the Surgical Robotics Leader Is Taking Aim at Cardiac Surgery Again · June 12, 2026 · 1h 2m
• Lisa Earnhardt on Abbott’s Innovation Strategy and the Future of Patient-Centered Care · June 5, 2026 · 1h 15m
• A Focused View of EDOF™ Technology from a GI Clinician · June 2, 2026 · 34 min
• DeviceTalks Boston Wrap Up with the Editors (and Many Special Guests!) · May 29, 2026 · 35 min
• Axoft is building a BCI success story in Massachusetts; MassMEDIC's Johnson on MedTech’s future · May 22, 2026 · 1h 8m
• High-Stakes Decision-Making is an Art – Boston Scientific, Cryosa, Provation · May 19, 2026 · 1h 8m